Excipient Grade, Xeno-Free for bioparmaceuticals
• Source: Rice Grain (Oryza Sativa)
• CAt No: HYC002C02
• Appearance: Slightly viscous, yellow clear liquid; not turbid
• Package: 50ml, 10g/vial
Excipient Grade, Xeno-Free for bioparmaceuticals
• Source: Rice Grain (Oryza Sativa)
• CAt No: HYC002C02
• Appearance: Slightly viscous, yellow clear liquid; not turbid
• Package: 50ml, 10g/vial
Human serum albumin (HSA) is the most well studied plasma protein and an attractive macromolecular carrier due to its availability in pure form and its biodegradability, nontoxicity and non-immunogenicity. It has a serum half-life of approximately 20 days, and is widely used as a stabilizing component in pharmaceutical and biologic products, such as vaccines, cell and gene therapies and coatings for medical devices. Due to the potential existence of various infectious disease pathogens in the human blood, especially AIDS, hepatitis B and other viruses, these virus may be brought with HSA to the final products.
OsrHSA Premium, a recombinant human serum albumin derived from rice grains, can provide an excellent solution to utilise a safer, more defined and consistent material. Compared to plasma human serum albumin (pHSA), OsrHSA Premium has the same second and tertiary structure, physiological and biochemical properties with pHSA, while higher purity and excellent batch consistency.
Chemical Defined & Animal-Free;
High Batch-to-Batch Consistancy;
Stable Bulk Supply
cGMP Manufactured
DMF(No.29648)
| Items | OsrHSA (rice-derived) | ScrHSA (yeast-derived) |
| Safety | Free of animal, Virus, Pathogene, low endotoxin | Possible residual yeast cell wall components (such as B-glucan),additional removal of endotoxins required |
| Post-translational modifications | No glycosylation modification, structure identical to native HSA | Glycosylation modification, Risk of inclusion formation requires reproducibility |
| Production process | Simple process with Three-step chromatography purification | High-density fermentation is costly, with more complex production process |
| Scale up | Low-cost in rice cultivation Long-term stable storage in rice seeds Single-batch purification cycle: 24h Low immunogenicity, suitable for stem/primary cells, high batch consistency |
High capital investment for fermentation equipmentSingle-batch production cycle:3-7 days Residual host proteins affect cell growth, batch difference exists |
| Cell culture compatibility | ||
| Regulation and ethics | Comply with regulations and shorten the filing time, environmentally fri endly and sustainable |
Microbial fermentation requires strict GMP control, Acceptance of genetically modified yeast varies by region |
Virus vaccine production
Cell therapy & Gene therapy
In vitro fertilization cryopreservation
Regenerative medicine& Tissue storage
Medical Source coating & Surgical sealants
Yes, we do. From our comparative test, OsrHSA is structurelly and biochemically equivalent to pHSA, and functions equivalently to pHSA in terms of binding capacity and promotion of cell growth. In addition, OsrHSA displays the same immunogenicity as pHSA.
Yes, we do. From our comparative test, OsrHSA is structurelly and biochemically equivalent to pHSA, and functions equivalently to pHSA in terms of binding capacity and promotion of cell growth. In addition, OsrHSA displays the same immunogenicity as pHSA.
Yes, we do. From our comparative test, OsrHSA is structurelly and biochemically equivalent to pHSA, and functions equivalently to pHSA in terms of binding capacity and promotion of cell growth. In addition, OsrHSA displays the same immunogenicity as pHSA.
Yes, we do. From our comparative test, OsrHSA is structurelly and biochemically equivalent to pHSA, and functions equivalently to pHSA in terms of binding capacity and promotion of cell growth. In addition, OsrHSA displays the same immunogenicity as pHSA.
Leave a message!
Leave a message!